Comparison Of The Efficacy Of Interfascial Hydrodissection With A Mixture Of Lidocaine And Physiological Saline Solution With 10% Dextrose In Patients With Chronic Neck Pain
CompletedNot applicableNCT07503574
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Objective: This study aimed to investigate the effects of fascial hydrodissection with 10% dextrose or lidocaine-saline on pain, neck functions, and quality of daily life in patients with chronic neck pain due to resistant myofascial trigger points in the upper trapezius muscle unresponsive to conservative treatments, and to determine whether one solution is superior to the other. Materials and Methods: This study is designed as prospective, comparative clinical study. The first group will be applied interfascial hydrodissection with 10% dextrose, and the second group with lidocaine-saline. All participants will be instructed in self-massage and stretching exercises to perform at home to support treatment efficacy. Interventions will be performed under ultrasound guidance, targeting the specified interfascial plane. Evaluations will be conducted at baseline, at 10 minutes post-treatment (VAS, ROM), and at 1-month and 3-month follow-ups (VAS, ROM, NDI, SF-12). Data will be statistically analyzied by comparing pre- and post-treatment measurements.
Study details
- Official title
- Comparison Of The Efficacy Of Interfascial Hydrodissection With A Mixture Of Lidocaine And Physiological Saline Solution Wıth 10% Dextrose In Patients With Chronic Neck Pain Associated With Resistant Myofascial Trigger Points In The Upper Trapezius
- Conditions
- Myofascial Pain Syndrome
- Trigger Point Pain, Myofascial
- Neck Pain
- Interventions
- Drug: % 10 dextrose Hydrodissection
- Drug: Lidocaine-Saline Hydrodissection
- Sponsor
- Ankara University
- Collaborators
- Ankara Training and Research Hospital
- Start date
- 2025-04-30
- Primary completion
- 2025-07-30
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients aged 18-65 years old * Chronic neck pain associated with MAS in the upper trapezius for at least 3 months and a VAS score above 5 * Compliance with the MAS criteria defined by Travel and Simons (five major and one minor criterion) * Lack of response to conservative treatment methods such as medical and physical therapy for neck pain * Willingness to participate in the study Exclusion Criteria: * Previous surgery on the shoulder or cervical region * History of neck and shoulder trauma * Presence of fibromyalgia syndrome * Presence of cervical radiculopathy or shoulder pathologies * Patients who have undergone injection or physical therapy program within the last three months * History of lidocaine allergy * Presence of coagulopathy * Presence of rheumatological and neurological diseases * Patients with uncontrolled diabetes mellitus * Presence of severe psychiatric comorbidity * Presence of local or systemic infection * Presence of needle phobia
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07503574